Nuvation Bio Inc (NYSE: NUVB) open the trading on Thursday, with great promise as it jumped 3.07% to $2.69, before settling in for the price of $2.61 at the close. Taking a more long-term approach, NUVB posted a 52-week range of $1.39-$4.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare sector firm’s twelve-monthly sales growth has been 0.00% for the last half of the decade. Nevertheless, stock’s Earnings Per Share (EPS) this year is -510.95%. This publicly-traded company’s shares outstanding now amounts to $335.25 million, simultaneously with a float of $229.10 million. The organization now has a market capitalization sitting at $908.06 million. At the time of writing, stock’s 50-day Moving Average stood at $2.60, while the 200-day Moving Average is $2.87.
Nuvation Bio Inc (NUVB) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Nuvation Bio Inc’s current insider ownership accounts for 32.13%, in contrast to 43.31% institutional ownership. According to the most recent insider trade that took place on Nov 11 ’24, this organization’s CEO, ANHEART THERAPEUTICS LTD. sold 56,361 shares at the rate of 2.89, making the entire transaction reach 162,883 in total value, affecting insider ownership by 3,866,228. Preceding that transaction, on Oct 08 ’24, Company’s Director bought 100,000 for 2.20, making the whole transaction’s value amount to 220,000. This particular insider is now the holder of 100,000 in total.
Nuvation Bio Inc (NUVB) Earnings and Revenue Records
Nuvation Bio Inc’s EPS decrease for this current 12-month fiscal period is -510.95% and is forecasted to reach -0.58 in the upcoming year.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
Let’s observe the current performance indicators for Nuvation Bio Inc (NUVB). It’s Quick Ratio in the last reported quarter now stands at 9.57. The Stock has managed to achieve an average true range (ATR) of 0.17. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 420.40.
In the same vein, NUVB’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.17, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be -0.58 at the market close of one year from today.
Technical Analysis of Nuvation Bio Inc (NUVB)
[Nuvation Bio Inc, NUVB] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 39.29% While, its Average True Range was 0.17.
Raw Stochastic average of Nuvation Bio Inc (NUVB) in the period of the previous 100 days is set at 35.03%, which indicates a major rise in contrast to 34.62% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 53.06% that was lower than 70.62% volatility it exhibited in the past 100-days period.
